Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,964 public trials 1,826 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Active, Not Recruiting

Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation

NCT05968963

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +15 more
Locations: University of Miami Miami, Florida, United States

View Trial Details

Active, Not Recruiting

CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLL

NCT00586391

Conditions: Acute Lymphocytic Leukemia, B Cell Lymphoma, Chronic Disease, +20 more
Locations: Houston Methodist Hospital Houston, Texas, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Active, Not Recruiting

EBV CTLs Expressing CD30 Chimeric Receptors For CD 30+ Lymphoma

NCT01192464

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +9 more
Locations: Houston Methodist Hospital Houston, Texas, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Venetoclax and Ibrutinib in Treating in Participants With Chronic Lymphocytic Leukemia and Ibrutinib Resistance Mutations

NCT03513562

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

A Phase IIa Clinical Study of Purinostat Mesylate for Injection in Patients With Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma

NCT06485219

Conditions: Cutaneous T-cell Lymphoma (CTCL), Disease Attributes, Hemic and Lymphatic Diseases, +15 more
Locations: Ruijin Hospital, Shanghai Jiaotong University School Of Medicine Shanghai, Shanghai Municipality, China

West China Hospital Sichuan University Chengdu, Sichuan, China

View Trial Details

Active, Not Recruiting

Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma

NCT03749018

Conditions: Aggressive Non-Hodgkin Lymphoma, Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma, +22 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma

NCT06097364

Conditions: Disease Attributes, Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, +12 more
Locations: Boca Raton Clinical Research (BRCR) Global Plantation, Florida, United States

Investigative Clinical Research of Indiana Noblesville, Indiana, United States

Cancer Center of Kansas Wichita, Kansas, United States

University of Kentucky Lexington, Kentucky, United States

View all 145 locations

View Trial Details

Active, Not Recruiting

Italian Real-World Study of Epcoritamab in Relapsed or Refractory DLBCL

NCT07393204

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: IRCCS Ospedale San Raffaele Milan, Italy

View Trial Details

Active, Not Recruiting

Cognitive Screening Made Easy for PCPs - R33 Phase

NCT06162026

Conditions: Brain Diseases, Central Nervous System Diseases, Cognition Disorders, +18 more
Locations: Family Wellness Clinic Austin, Texas, United States

View Trial Details

Active, Not Recruiting

Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL

NCT04938232

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +9 more
Locations: University of Chicago Medicine Chicago, Illinois, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions